Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jun 17, 2021 8:31pm
50 Views
Post# 33409223

RE:RE:Kedrion option extension announced 2 days late

RE:RE:Kedrion option extension announced 2 days late Stups, you just jumped on the band wagon yesterday.  Today your off and we are now selling again.  ROF  Make up your mind doofus.

Your response to your other ID:

I think the same man! Like i said, I hope we keep riplazym! Cant wait to read the spammers if we do! After saying a million times we gave away the golden goose.

In fact we had a good deal (100M$), but riplazym is a real business with recurring good revenues... they are hiring people to launch it! So looks good.

We will know soon.

 

 

Newcamo wrote:

i really wish  the deal with kedrion doesnt go through, and lmnl keeps riplazym! 100M$ is nice but mid term, LMNL would make a lot more commercialising riplazym... they are hiring production people, lets see! Personnally im loading up...



realstocky wrote:

what are u babbling about, its paper work delays, who cares:) the deal is obviously going forward if they extended it for a week. Good news. Is some other news responsable for that lil delay?

 

stockbuphoon wrote:

 

This is just a rookie management team or doing this stuff on purpose which is even more evil.

This Report on Form 6-K (the “Report”) is hereby expressly incorporated by reference into the registrant’s registration statements on Form F-3 (File nos. 333-251055, 333-245703 and 333-251065) filed with the Securities and Exchange Commission on December 1, 2020, December 2, 2020 and December 2, 2020, respectively, and the registration statement on Form S-8 (File no. 333-
235692) filed with the Securities and Exchange Commission on December 23, 2019.

 

Extension of the Option Agreement entered into between Liminal BioSciences Inc. and Kedrion S.p.A.

 

Liminal Biosciences Inc. (the “Company”) today announced that it has amended the Option Agreement it entered into with Kedrion S.p.A. on May 21, 2021 to extend the option exercise period under such Option Agreement from June 15, 2021 to June 22, 2021.

 





<< Previous
Bullboard Posts
Next >>